Adaptive Biotechnologies (ADPT.US) stock price is influenced by several factors. Company Performance: Revenue growth, earnings reports, and progress in developing and commercializing its immune medicine platform drive investor confidence.

Clinical Trial Results: Positive data from clinical trials using their clonoSEQ assay or other diagnostic tools can significantly boost stock value.

Partnerships and Collaborations: Strategic alliances with pharmaceutical companies or research institutions can increase market reach and validation.

Market Sentiment: Overall investor mood towards biotechnology and healthcare stocks impacts ADPT.US, reflecting broader economic trends and risk appetite.

Competition: The presence and success of competing technologies or companies in the immune profiling and diagnostics space can influence investor perceptions.

Regulatory Landscape: Changes in regulations regarding diagnostic testing or reimbursement policies can affect the company's revenue potential.

Technological Advancements: Breakthroughs in immune sequencing and data analysis that improve ADPT's platform could drive stock appreciation.

Macroeconomic Factors: Interest rates, inflation, and economic growth can indirectly affect ADPT.US by influencing investor behavior and valuation models.